Milan, Italy, April 6, 2011 – Newron Pharmaceuticals S.p.A. (“Newron”), publishes today the invitation to the Annual General Meetings which will take place on 27 April 2011 in Bresso
(MI), Italy (first call).

Items on the agenda include:

• Approval of the financial statements as of 31 December 2010; related resolutions.

• Appointment of the Board of Directors for the fiscal years 2011, 2012 and 2013, prior redetermination of the number of relevant members, and changes to the Article 14 of the Bylaws, and determination of their compensation; related resolutions.

• Increase in the Company’s share capital up to 10% of the Company’s share capital as
permitted by Article 2441, paragraph 4, second sentence of the Italian Civil Code; related resolutions;

• Amendment of Articles 9, 12 and 13 of the By-Laws in order to implement the changes introduced in the Civil Code by Legislative Decree 27/2010 implementing the EC Directive 36/2007, and in particular: (i) inclusion of the possibility of excluding the use of further
calls of the shareholders’ meetings following the first call, (ii) changes to literally reflect the new wording requested by the Civil Code in connection with the validity of shareholders’ meetings; related resolutions.

The full invitation, incl. detailed information for shareholders, is available on http://www.newron.com/shareholdersmeeting.html